Scott Floyd

ORCID: 0000-0002-8067-2426
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Brain Metastases and Treatment
  • Glioma Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Meningioma and schwannoma management
  • Advanced Radiotherapy Techniques
  • Radiopharmaceutical Chemistry and Applications
  • Cancer Research and Treatments
  • Radiomics and Machine Learning in Medical Imaging
  • Protein Degradation and Inhibitors
  • Cell Image Analysis Techniques
  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • CRISPR and Genetic Engineering
  • Management of metastatic bone disease
  • Brain Tumor Detection and Classification
  • DNA Repair Mechanisms
  • Lung Cancer Diagnosis and Treatment
  • 3D Printing in Biomedical Research
  • Histone Deacetylase Inhibitors Research
  • RNA Interference and Gene Delivery
  • Lung Cancer Treatments and Mutations
  • Genomics and Chromatin Dynamics
  • Cancer Genomics and Diagnostics
  • Spine and Intervertebral Disc Pathology
  • Cancer Immunotherapy and Biomarkers

Duke University
2016-2025

Duke Medical Center
2016-2025

Duke Cancer Institute
2020-2024

Massachusetts Institute of Technology
2013-2023

Duke University Hospital
2019-2023

Durham VA Medical Center
2021

Allen Institute
2020

Duke University Health System
2017-2019

Beth Israel Deaconess Medical Center
2008-2018

Harvard University
2005-2017

Endophilin 1 is a presynaptically enriched protein which binds the GTPase dynamin and polyphosphoinositide phosphatase synptojanin. Perturbation of endophilin function in cell-free systems living synapse has implicated endocytic vesicle budding (Ringstad, N., H. Gad, P. Low, G. Di Paolo, L. Brodin, O. Shupliakov, De Camilli. 1999. Neuron. 24:143–154; Schmidt, A., M. Wolde, C. Thiele, W. Fest, Kratzin, A.V. Podtelejnikov, Witke, W.B. Huttner, H.D. Soling. Nature. 401:133–141; H., N. Ringstad,...

10.1083/jcb.200107075 article EN The Journal of Cell Biology 2001-10-15

Effective treatment for glioblastoma (GBM) is limited by the presence of blood-brain barrier (BBB) and rapid resistance to single agent therapies. To address these issues, we developed a transferrin-functionalized nanoparticle (Tf-NP) that can deliver dual combination Using intravital imaging, show ability Tf-NPs traverse intact BBB in mice as well achieve direct tumor binding two intracranial orthotopic models GBM. Treatment tumor-bearing with loaded temozolomide bromodomain inhibitor JQ1...

10.1038/s41467-018-04315-4 article EN cc-by Nature Communications 2018-05-14

BackgroundThe dismal survival of glioblastoma (GBM) patients urgently calls for the development new treatments. Chimeric antigen receptor T (CAR-T) cells are an attractive strategy, but preclinical and clinical studies in GBM have shown that heterogeneous expression antigens targeted so far causes tumor escape, highlighting need identification targets. We explored if B7-H3 is a valuable target CAR-T GBM.MethodsWe compared mRNA using TCGA data, validated by immunohistochemistry. then tested...

10.1016/j.ebiom.2019.08.030 article EN cc-by-nc-nd EBioMedicine 2019-08-26

<h3>Background</h3> Ipilimumab improves survival in metastatic melanoma patients. This population frequently develops brain metastases, which have been associated with poor and are often treated radiation. Therefore, outcomes following ipilimumab radiation of interest, especially given case reports animal studies suggest combined treatment may generate abscopal responses outside the field. <h3>Findings</h3> We reviewed sixteen consecutive patients who received 1 to 8 courses radiation, a sum...

10.1186/s40425-015-0095-8 article EN cc-by Journal for ImmunoTherapy of Cancer 2015-10-21

Abstract A significant proportion of patients with brain metastases experience a seizure event during their disease course, which can impact morbidity and long-term outcomes. host factors elevate the risk for seizures in metastases, including patient factors, metabolic imbalances, tumor burden, treatment modality. While reducing burden via local systemic therapies remains critical component to mitigating events, select may remain at risk. The use prophylactic anti-seizure medications be...

10.1093/nop/npaf001 article EN Neuro-Oncology Practice 2025-01-13
Dominic LaBella Ujjwal Baid Omaditya Khanna Shan McBurney-Lin Ryan McLean and 95 more Pierre Nedelec Arif Rashid Nourel Hoda Tahon Talissa A. Altes Radhika Bhalerao Yaseen Dhemesh D Godfrey Fathi Hilal Scott Floyd Anastasia Janas Anahita Fathi Kazerooni John P. Kirkpatrick Collin Kent Florian Kofler Kevin Leu Nazanin Maleki Bjoern Menze Maxence Pajot Zachary J. Reitman Jeffrey D. Rudie Rachit Saluja Yury Velichko Chunhao Wang Pranav Warman Maruf Adewole Jake Albrecht Udunna Anazodo Syed Muhammad Anwar Timothy Bergquist Sully Francis Chen Verena Chung Rong Chai Gian-Marco Conte Farouk Dako J. Mark Eddy Ivan Ezhov Nastaran Khalili Juan Eugenio Iglesias Zhifan Jiang Elaine Johanson Koen Van Leemput Hongwei Li Marius George Linguraru Xinyang Liu Aria Mahtabfar Zeke Meier Ahmed W. Moawad John Mongan Marie Piraud Russell Takeshi Shinohara Walter F. Wiggins Aly Abayazeed Rachel Akinola András Jakab Michel Bilello Maria Correia de Verdier Priscila Crivellaro Christos Davatzikos Keyvan Farahani John Freymann Christopher P. Hess Raymond Y. Huang Philipp Lohmann Mana Moassefi Matthew W. Pease Phillipp Vollmuth Nico Sollmann David Diffley Khanak Nandolia Dan Warren Ali Hussain Pascal Fehringer Yulia Bronstein Lisa Deptula Evan G. Stein Mahsa Taherzadeh Eduardo Portela de Oliveira Aoife Haughey Marinos Kontzialis Luca Saba Benjamin Turner Melanie Brüßeler Shehbaz Ansari Athanasios Gkampenis David Maximilian Weiss Aya Mansour Islam H. Shawali Nikolay Yordanov Joel M. Stein Roula Hourani Mohammed Yahya Moshebah Ahmed Magdy Abouelatta Tanvir Rizvi Klara Willms Dann C. Martin

We describe the design and results from BraTS 2023 Intracranial Meningioma Segmentation Challenge. The Challenge differed prior Glioma challenges in that it focused on meningiomas, which are typically benign extra-axial tumors with diverse radiologic anatomical presentation a propensity for multiplicity. Nine participating teams each developed deep-learning automated segmentation models using image data largest multi-institutional systematically expert annotated multilabel multi-sequence...

10.59275/j.melba.2025-bea1 article EN The Journal of Machine Learning for Biomedical Imaging 2025-03-07

This cohort study evaluates whether immune-checkpoint inhibition therapy concurrent with radiosurgery is associated risk of symptomatic radionecrosis among US patients brain metastases.

10.1001/jamanetworkopen.2025.4347 article EN cc-by-nc-nd JAMA Network Open 2025-04-09

Effective spatio-temporal control of transcription and replication during S-phase is paramount to maintaining genomic integrity cell survival. Dysregulation these systems can lead conflicts between the machinery, causing DNA damage death. BRD4 allows efficient transcriptional elongation by stimulating phosphorylation RNA polymerase II (RNAPII). We report that bromodomain extra-terminal domain (BET) protein loss function (LOF) causes RNAPII pausing on chromatin affecting cells in S-phase....

10.1016/j.celrep.2020.108166 article EN cc-by-nc-nd Cell Reports 2020-09-01

To develop a neural ordinary differential equation (ODE) model for visualizing deep network behavior during multi-parametric MRI-based glioma segmentation as method to enhance learning explainability.

10.1002/mp.16286 article EN Medical Physics 2023-02-25

A key modality of non-surgical cancer management is DNA damaging therapy that causes double-strand breaks are preferentially toxic to rapidly dividing cells. Double-strand break repair capacity recognized as an important mechanism in drug resistance and therefore a potential target for adjuvant chemotherapy. Additionally, spontaneous environmentally induced DSBs known promote cancer, making DSB evaluation tool epidemiology, clinical the development novel pharmaceuticals. Currently available...

10.4161/cc.23880 article EN Cell Cycle 2013-02-19

Utilization of stereotactic radiosurgery (SRS) for brain metastases (BM) has increased, prompting reassessment whole radiation therapy (WBRT). A pattern care analysis SRS and WBRT dose-fractionations was performed in patients presenting with BM at the time cancer diagnosis.Adults diagnosis between 2010 to 2015 no prior malignancy were identified National Cancer Database. defined using published thresholds. Short (ShWBRT), standard (StWBRT), extended (ExWBRT) as 4 9, 10 15, >15 fractions....

10.1016/j.adro.2019.07.012 article EN cc-by-nc-nd Advances in Radiation Oncology 2019-07-26

Functional precision medicine platforms are emerging as promising strategies to improve pre-clinical drug testing and guide clinical decisions. We have developed an organotypic brain slice culture (OBSC)-based platform multi-parametric algorithm that enable rapid engraftment, treatment, analysis of uncultured patient tumor tissue patient-derived cell lines. The has supported engraftment every tested this point: high- low-grade adult pediatric rapidly establishes on OBSCs among endogenous...

10.1016/j.xcrm.2023.101042 article EN cc-by Cell Reports Medicine 2023-05-15

Abstract Meningiomas are the most common primary intracranial tumors and can be associated with significant morbidity mortality. Radiologists, neurosurgeons, neuro-oncologists, radiation oncologists rely on brain MRI for diagnosis, treatment planning, longitudinal monitoring. However, automated, objective, quantitative tools non-invasive assessment of meningiomas multi-sequence MR images not available. Here we present BraTS Pre-operative Meningioma Dataset, as largest multi-institutional...

10.1038/s41597-024-03350-9 article EN cc-by Scientific Data 2024-05-15
Coming Soon ...